Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
IMDX
Stock Latest News
Company Announcements
Insight Molecular Corrects Bylaws Disclosure in Annual Report
9d ago
8K
IMDX
Premium
Ratings
Insight Molecular Diagnostics: Building Momentum with GraftAssure Platform and Favorable Risk‑Reward Supporting Buy Rating
23d ago
IMDX
Premium
Company Announcements
OncoCyte Earnings Call: GraftAssureDx Drives Pivot
1M ago
IMDX
Premium
Ratings
Buy Rating on IMDX Driven by Strong GraftAssure Traction, Upcoming FDA Catalyst, and Solid Balance Sheet
1M ago
IMDX
Premium
The Fly
Insight Molecular Diagnostics submits GraftAssureDx for FDA review
1M ago
IMDX
Premium
The Fly
Insight Molecular Diagnostics reports Q4 EPS (27c) vs. (28c) last year
1M ago
IMDX
Premium
Pre-Earnings
OCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
IMDX
Premium
The Fly
Insight Molecular Diagnostics highlights publication of study on GraftAssure
2M ago
IMDX
Premium
The Fly
Insight Molecular Diagnostics completes milestones advancing GraftAssureDx
2M ago
IMDX
Premium
Ratings
Insight Molecular Diagnostics: GraftAssureIQ Validation and Hospital Adoption Set Up 2026 as a Growth Inflection Year
2M ago
IMDX
Premium
Company Announcements
Insight Molecular Diagnostics Signs Quest Specimen Collection Agreement
2M ago
8K
IMDX
Premium
The Fly
Insight Molecular Diagnostics price target raised to $12 from $8 at Lake Street
3M ago
IMDX
Premium
Company Announcements
Insight Molecular Diagnostics Raises Capital to Advance Transplant R&D
3M ago
8K
IMDX
Premium
Company Announcements
Insight Molecular Diagnostics Provides Updated Investor Presentation Materials
3M ago
8K
IMDX
Premium
The Fly
Insight Molecular Diagnostics prices 4.53M shares at $5.75 in direct offering
3M ago
IMDX
Premium
The Fly
Insight ‘congratulated’ STAR working group on organ health testing paper
4M ago
IMDX
Premium
The Fly
Insight Molecular Diagnostics appoints Nick Ioannou as VP, medical affairs
4M ago
IMDX
Premium
Ratings
Regulatory Momentum and Expanding Clinical Footprint Position Insight Molecular Diagnostics for a Pivotal 2026 Ramp
4M ago
IMDX
Premium
The Fly
iMDx prepares for U.S. commercial launch of GraftAssureDx
4M ago
IMDX
Premium
The Fly
Fourteen new option listings on November 12th
6M ago
MST
PRE
Premium
Company Announcements
OncoCyte Corp’s Earnings Call: Progress Amid Challenges
6M ago
IMDX
Premium
Ratings
Insight Molecular Diagnostics: Promising Growth with GraftAssureIQ and Strategic Expansion Plans Reinforce Buy Rating
6M ago
IMDX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
